Clinical Trials Logo

Clinical Trial Summary

Safety and efficacy of 0.75% Phentolamine Ophthalmic Solution to improve mesopic low contrast visual acuity in subjects with post-refractive surgery visual disturbances.


Clinical Trial Description

Randomized, placebo-controlled, double-masked study of the safety and efficacy of POS (0.75% Phentolamine Ophthalmic Solution) in subjects who have previously had keratorefractive surgery and have decreased visual acuity (VA) under mesopic conditions ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06349759
Study type Interventional
Source Ocuphire Pharma, Inc.
Contact Drey V Coleman
Phone 248-681-9815
Email dcoleman@ocuphire.com
Status Recruiting
Phase Phase 3
Start date April 1, 2024
Completion date November 2025